(Q43852488)

27 November 2017

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy (English)

1 reference

27 November 2017

Franco Cecchi

5

0 references

Barry J Maron

1

object named as

Barry J Maron

1 reference

27 November 2017

Iacopo Olivotto

2

1 reference

27 November 2017

Pietro Bellone

3

1 reference

27 November 2017

Maria Rosa Conte

4

1 reference

27 November 2017

Björn P Flygenring

6

1 reference

27 November 2017

Susan A Casey

7

1 reference

27 November 2017

Thomas E Gohman

8

1 reference

27 November 2017

Sergio Bongioanni

9

1 reference

27 November 2017

Paolo Spirito

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Journal of the American College of Cardiology

27 November 2017

1 reference

27 November 2017

39

1 reference

27 November 2017

301-307

1 reference

27 November 2017

2

1 reference

Hypertrophic cardiomyopathy

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

The management of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Epidemiology of Hypertrophic Cardiomyopathy–Related Death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Ischemic cerebrovascular complications and risk factors in idiopathic hypertrophic subaortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Clinical course of hypertrophic cardiomyopathy in a regional United States cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Color Doppler assessment of mitral regurgitation with orthogonal planes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Echocardiographic measurements in normal subjects from infancy to old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Stroke Incidence, Case Fatality, and Mortality in the WHO MONICA Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Duration of atrial fibrillation and imminence of stroke: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901727-2

7 January 2021

10.1016/S0735-1097(01)01727-2

Identifiers

DOI

1 reference

27 November 2017

1 reference